NGF-1

The Painful Death of a Promising Drug Class
Motley Fool
Thu, 12/30/10 - 10:53 am
Regeneron
Sanofi
JNJ
AstraZeneca
NGF-1
Promising Pain Drugs Put On Ice
Forbes
Tue, 12/28/10 - 10:45 am
painkillers
Pfizer
Regeneron
Sanofi
NGF-1